Lipocine Inc. (LPCN)
NASDAQ: LPCN · IEX Real-Time Price · USD
5.27
-0.17 (-3.13%)
At close: Apr 19, 2024, 4:00 PM
5.17
-0.10 (-1.90%)
After-hours: Apr 19, 2024, 5:27 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 33, which predicts an increase of 526.19% from the current stock price of 5.27.
Analyst Consensus: Buy
* Price targets were last updated on Jul 27, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $33 | Buy | Reiterates | $33 | +526.19% | Jul 27, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 26, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 24, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 27, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Dec 10, 2020 |
Financial Forecast
Revenue This Year
2.07M
from -2.85M
Revenue Next Year
16.58M
from 2.07M
Increased by 702.03%
EPS This Year
-1.52
from -3.14
EPS Next Year
-0.58
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1M | 17.1M | 37.1M | 27.8M | 53.8M |
| Avg | 2.1M | 16.6M | 36.0M | 27.0M | 52.2M |
| Low | 2.0M | 15.9M | 34.6M | 26.0M | 50.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 725.6% | 123.6% | -22.7% | 98.9% |
| Avg | - | 702.0% | 117.2% | -24.9% | 93.2% |
| Low | - | 670.6% | 108.7% | -27.9% | 85.6% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.56 | -0.60 |
| Avg | -1.52 | -0.58 |
| Low | -1.46 | -0.56 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.